Department of Dermatology, PLA General Hospital, Beijing, China.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics, Beijing, China.
Biochem Biophys Res Commun. 2020 Apr 9;524(3):567-574. doi: 10.1016/j.bbrc.2020.01.131. Epub 2020 Feb 1.
Hypereosinophilic syndrome (HES) is a rare multisystem disease that predominantly includes skin with severe and persistent itching. A lack of understanding about the pathological condition and mechanism of dermatosis caused by HES hinders its treatment. In the present study, we applied a quantitative proteomics approach to characterize the cellular responses of skin tissue to idiopathic HES (IHES) at the proteome level. We identified hundreds of skin tissue proteins that were differentially expressed between IHES patients and healthy individuals. IHES patients display severely damaged microenvironment, including extracellular matrix (ECM) organization and disassembly, immune disorders, decreased metabolic capacity, and susceptibility to microbial infection. Moreover, there was abnormal proliferation of basal epidermal stem cells, which was closely related to high expression of the epigenetic regulator, histone deacetylase 2, providing mechanistic insight into the abnormal epidermal thickening of IHES skin tissues. Overall, our study provides a comprehensive framework for a system-level understanding of IHES-induced dermatosis (IHESiD) tissues at the protein and cell pathway levels. Our findings may facilitate a new approach to diagnosis and treatment to alleviate skin clinical symptoms, monitor the activity of IHES, and determine therapeutic effects.
高嗜酸性粒细胞综合征 (HES) 是一种罕见的多系统疾病,主要表现为皮肤严重且持续瘙痒。由于对 HES 引起的皮肤病的病理状况和机制缺乏了解,阻碍了其治疗。在本研究中,我们应用定量蛋白质组学方法在蛋白质组水平上描述了皮肤组织对特发性 HES (IHES) 的细胞反应。我们鉴定了数百种在 IHES 患者和健康个体之间差异表达的皮肤组织蛋白。IHES 患者表现出严重受损的微环境,包括细胞外基质 (ECM) 组织和分解、免疫紊乱、代谢能力下降以及易受微生物感染。此外,基底表皮干细胞异常增殖,这与表观遗传调节剂组蛋白去乙酰化酶 2 的高表达密切相关,为 IHES 皮肤组织异常表皮增厚提供了机制上的见解。总的来说,我们的研究为在蛋白质和细胞途径水平上系统地理解 IHES 诱导的皮肤病 (IHESiD) 组织提供了一个全面的框架。我们的发现可能有助于为减轻皮肤临床症状、监测 IHES 活动和确定治疗效果提供新的诊断和治疗方法。